US equities
|
MU
$972.11
▲+4.67%
META
$613.65
▼-1.05%
TSLA
$401.84
▼-1.38%
SPCX
$145.02
▼-2.40%
SNDK
$1,383.72
▲+6.05%
NVDA
$217.69
▼-0.11%
SKHY
$162.81
▲+12.00%
GOOGL
$323.79
▲+1.00%
MU
$972.11
▲+4.67%
META
$613.65
▼-1.05%
TSLA
$401.84
▼-1.38%
SPCX
$145.02
▼-2.40%
SNDK
$1,383.72
▲+6.05%
NVDA
$217.69
▼-0.11%
SKHY
$162.81
▲+12.00%
GOOGL
$323.79
▲+1.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about J/R/ Rahn
Recent news which mentions J/R/ Rahn
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
April 04, 2022
Tickers
MNMD
Tags
Small Cap
Markets
Benzinga
From
Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
December 10, 2021
Tickers
MNMD
NDAQ
Tags
NDAQ
Small Cap
Robert Barrow
From
Benzinga
EXCLUSIVE: Kevin O'Leary Unpacks Deal Flow, Investments, Perspectives On Disruptive Innovation
August 31, 2021
Tickers
IPOS
MNMD
Tags
Penny Stocks
StartEngine
MindMed
From
Benzinga